Heartflow, Inc. (HTFL) vs 10x Genomics (TXG)
Heartflow, Inc. and 10x Genomics are both Health Information Services companies. 10x Genomics is the larger, with a market value of $11.1B against $4.2B — 2.6× the size. Heartflow, Inc. grew revenue faster over the last twelve months: 42.8% against −4.28%. 10x Genomics has the higher net margin (−12.2% vs −55.8%) and the higher return on invested capital (−20.2% vs −42.8%). Across the 16 metrics below, 10x Genomics leads on 11 and Heartflow, Inc. on 5.
Valuation
Profitability
| Metric | HTFL | TXG | Health Information Services median |
|---|---|---|---|
| Gross margin | 80.08% | 70.03% | 63.38% |
| Operating margin | (37.84%) | (14.33%) | (8.35%) |
| Net margin | (55.82%) | (12.18%) | (14.70%) |
| Free cash flow margin | (27.91%) | 19.68% | 0.58% |
| Return on equity | 38.49% | (9.40%) | (6.82%) |
| Return on assets | (46.99%) | (7.47%) | (6.02%) |
| Return on invested capital | (42.81%) | (20.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack